SHORT KG ( KING PHARMACEUTICAL ), BUY ALO (ALPHARMA)
KG today made public its $33 cash offer for ALO ( Alpharma ). Normally stock of the acquirer falls, but here KG stock has jumped.
Unrivaled Performance In Bull And Bear Markets. FREE TRIALS.
|
Proven Track Record of Most Accurate Analysis
Proven Track Record
of Most Accurate Analysis
The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts.
The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts.
KG today made public its $33 cash offer for ALO ( Alpharma ). Normally stock of the acquirer falls, but here KG stock has jumped.
As our readers know, we have been very negative on SNDK and have made money shorting it. Today stock dropped $1.79 following cautious comments by
Our indicators demand trimming of ERTS position right here at $48.67. A tight sell stop on rest of the position is desirable. www.thearorareport.com THE ARORA
With 17% gain in such a short period, our methodology calls for selling at least part of the position at $3.63 or better. Use tight
Our readers are well aware of correct calls on ANAD. We have been short. This morning’s reaction is severe overreaction . At $3.10 our indicators
We are short AKAM from $28. Our proprietary indicators are now flashing a BUY TO COVER signal. Cover right here at $21.84 www.thearorareport.com THE ARORA
On Aug 20, 2008, we starting shorting ANAD . If our methodology was followed, the average short price would have been around $18. On July
QCOM was down yesterday on its COO Sanjay Jha leaving to become co-CEO of Motorola. Contrary to market reaction, we see the development as positive